Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q2 2026)
288
Value
$4.99K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AMRX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026288$4.99K<0.1%−104−26.5%ReducedHolders
Q1 2026392$4.87K<0.1%+26+7.1%AddedHolders
Q4 2025366$4.61K<0.1%00.0%UnchangedHolders
Q3 2025366$3.66K<0.1%−118−24.4%ReducedHolders
Q2 2025484$3.92K<0.1%+15+3.2%AddedHolders
Q1 2025469$3.93K<0.1%+197+72.4%AddedHolders
Q4 2024272$2.15K<0.1%+118+76.6%AddedHolders
Q3 2024154$1.28K<0.1%00.0%UnchangedHolders
Q2 2024154$978<0.1%00.0%UnchangedHolders
Q1 2024154$933<0.1%−443−74.2%ReducedHolders
Q4 2023597$3.62K<0.1%+494+479.6%AddedHolders
Q3 2023103$435<0.1%−1,682−94.2%ReducedHolders
Q2 20231,785$5.53K<0.1%+458+34.5%AddedHolders
Q1 20231,327$1.84K<0.1%00.0%UnchangedHolders
Q4 20221,327$2.64K<0.1%+1,209+1,024.6%AddedHolders
Q3 2022118$00.0%−5,815−98.0%ReducedHolders
Q2 20225,933$19.0K<0.1%+5,111+621.8%AddedHolders
Q1 2022822$3.00K<0.1%−59−6.7%ReducedHolders
Q4 2021881$4.00K<0.1%−308−25.9%ReducedHolders
Q3 20211,189$7.00K<0.1%+116+10.8%AddedHolders
Q2 20211,073$5.00K<0.1%−368−25.5%ReducedHolders
Q1 20211,441$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.